Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis
- 1 March 1999
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 353 (9157), 964-969
- https://doi.org/10.1016/s0140-6736(98)03053-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-upBrain, 1998
- Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Clinical scoring methods for multiple sclerosisAnnals of Neurology, 1994
- Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesionsAnnals of Neurology, 1993
- Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- An attempt to quantify magnetic resonance imaging in multiple sclerosis — correlation with clinical parametersNeurosurgical Review, 1987
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983